USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
AURORA BIOSCIENCES CORPORATION
Address:
11010 TORREYANA RD
SAN DIEGO, CA 92121
Phone:
(858) 404-6613
URL:
N/A
EIN:
330669859
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $530,132.00 7
SBIR Phase II $985,624.00 2

Award List:

CYTOCHROME P450 INHIBITION SCREENS FOR METABOLISM

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Gregor Zlokarnik
Abstract:
Not Available Polarization imaging holds promise for providing significant improvements in contrast in a number of target detection and discrimination applications. In several recent development efforts, it has been demonstrated that manmade objects have a significantly stronger polarization signal… More

ID OF NOVEL BREAST CANCER AGENTS BY FUNCTIONAL GENOMICS

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Kleanthis G. Xanthopoulos
Abstract:
Not Available Goleta Engineering (GE) proposes to start with and build upon prior and on-going efforts such as the ONR ACTIVE and the DARPA MSTAR programs to develop a robust ISAR ATR capability for USN platforms such as the APY-6, APS-137, APG-73, and JSF. The proposed Phase I effort will focus on… More

IDENTIFICATION OF NOVEL IMMUNOSUPPRESSIVE AGENTS

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Kleanthis G. Xanthopoulos
Abstract:
Not Available Multispectral imaging offers significant advantages over conventional imaging by providing diversity data to detect camouflaged or low-contrast targets, reduce complex scene clutter and identify materials. Passive multispectral imaging is susceptible to undesirable and often… More

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase II
Award Amount:
$574,416.00
Agency:
HHS
Principal Investigator:
Gregor Zlokarnik
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Gregor Zlokarnik
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$130,132.00
Agency:
HHS
Principal Investigator:
Brian D. Hamman
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
David A. Nelson
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase II
Award Amount:
$411,208.00
Agency:
HHS
Principal Investigator:
David A. Nelson
Abstract:
N/a

NOVEL CELL-BASED ASSAY SYSTEM FOR VIRAL CIS-PROTEASES

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Jeffrey H. Stack
Abstract:
DESCRIPTION (Verbatim from Applicant's Abstract): We propose to design and develop an assay technology platform for viral proteases possessing cis cleavage activity. As viral cis proteases are frequently responsible for the initial cleavage of the viral polyprotein,… More